# OnCo record nct07312188 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07312188/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07312188", "NCT07312188" ;
  schema:name "A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma"@en ;
  schema:description "A phase 2 trial of F182112, Pomalidomide in multiple myeloma, run by Shandong New Time Pharmaceutical Co., LTD, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07312188/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07312188> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-07-02" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/myeloma-relapsed-refractory/> ;
  onco:drugs <https://onco.cc/drugs/f182112/>, <https://onco.cc/drugs/pomalidomide/> ;
  onco:companies <https://onco.cc/companies/shandong-new-time-pharmaceutical/> .